Before the U.S. Food and Drug Administration approved resmetirom (Resdifla), the first liver-targeting drug Metabolic dysfunction-associated steatohepatitis (MASH) Therapeutically, weight loss served as the cornerstone of...
Researchers at Vanderbilt University Medical Center (VUMC) are touting data from a multicenter, international Phase 2 clinical trial demonstrating a new treatment for sickle cell disease...
reflects the growing evidence base supporting the safety and effectiveness of these classes in management. type 2 diabetes The American College of Physicians supports SGLT2 inhibitors...
Although it is one of the most common diseases diagnosed by gastroenterologists, affecting 10-15% of people in the United States. Irritable bowel syndrome (IBS) It remains...
Boehringer Ingelheim will voluntarily impose a $35 monthly out-of-pocket cap on patients' out-of-pocket costs for products in its inhaler portfolio. Announced on March 7, 2024, Boehringer...
Rajeev H. Muni, MD, M.S. Credit: Unity Health Toronto The latest version of the artificial intelligence chatbot ChatGPT-4 correctly answered approximately two-thirds of image-based multiple-choice questions...
Recent Comments